咨询热线:

020-3107 8154

JSH-23

JSH-23是一种NF-κB转录活性抑制剂,其对LPS刺激的RAW 264.7 中的核因子(NF)-κB 转录活性具有抑制作用,IC50为 7.1 μM,并能干扰 LPS 诱导的 NF-κB核转位,而不影响 IκB 降解。

  • 货号:
    TK0346
  • 规格:
    1mg
    2mg
    5mg
  • 价格:
    0.00

产品参数

CAS No.749886-87-1
生物活性JSH-23 is an NF-κB inhibitor which inhibits NF-κB transcriptional activity with an IC50 of 7.1 μM in lipopolysaccharide (LPS)-stimulated macrophages RAW 264.7. JSH-23 inhibits nuclear translocation of NF-κB p65 without affecting IκBα degradation.
分子式C16H20N2
分子量240.34
运输条件Room temperature in continental US; may vary elsewhere.
储存条件 Powder -20°C 3 years
溶解性数据DMSO : ≥ 56 mg/mL (233.00 mM)
体内研究JSH-23 (1 mg/kg, 3 mg/kg; orally administered; daily; for 2 weeks) significantly reverses the nerve conduction and nerve blood flow deficits seen in diabetic rats.
体外研究JSH-2 (1-300 μM; 24 hours) at <100 μM does not show significant cytotoxic effects on the RAW 264.7 cells. Nuclear amount of NF-κB p65 is markedly increased upon exposure to LPS for 1 h. Treatment of JSH-23 (30 μM; 1 hours) to LPS- stimulated RAW 264.7 cells decreases nuclear content of NF-κB p65 in a dose-dependent manner.
纯度及产品资料98%